FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NiQuitin Pre-Quit Clear 21mg patches (GlaxoSmithKline Consumer Healthcare) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin Pre-Quit Clear 21mg patches (GlaxoSmithKline Consumer Healthcare) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testopatch 2.4mg/24hours transdermal patches (Imported (Greece)) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testopatch 2.4mg/24hours transdermal patches (Imported (Greece)) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 4.6mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 13.3 mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 4.6mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 13.3 mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 9.5mg/24hours transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 4.6mg/24hours transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 9.5mg/24hours transdermal patches (Teva UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 4.6mg/24hours transdermal patches (Teva UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sancuso 3.1mg/24hours transdermal patches (ProStrakan Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sancuso 3.1mg/24hours transdermal patches (ProStrakan Ltd) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 35micrograms/hour transdermal patches (Accord Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 52.5micrograms/hour transdermal patches (Accord Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 70micrograms/hour transdermal patches (Accord Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 35micrograms/hour transdermal patches (Accord Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 52.5micrograms/hour transdermal patches (Accord Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hapoctasin 70micrograms/hour transdermal patches (Accord Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (Pfizer Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Pfizer Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Pfizer Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Pfizer Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Pfizer Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (Actavis UK Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (Actavis UK Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 37.5microgram/hour transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 37.5microgram/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 37.5microgram/hour transdermal patches 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Waymade Healthcare Plc) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 37.5microgram/hour transdermal patches (Sandoz Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 4.6mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 9.5mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 4.6mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 9.5mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 50micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 75micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 100micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 25micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 50micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 75micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 100micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 9.5mg/24hours transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 4.6mg/24hours transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 9.5mg/24hours transdermal patches (Sandoz Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 4.6mg/24hours transdermal patches (Sandoz Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 4.6mg/24hours transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 9.5mg/24hours transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 4.6mg/24hours transdermal patches (Zentiva Pharma UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 9.5mg/24hours transdermal patches (Zentiva Pharma UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 4.6mg/24hours transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 9.5mg/24hours transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 4.6mg/24hours transdermal patches (Viatris UK Healthcare Ltd) 30 patch 5 x 6 patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 9.5mg/24hours transdermal patches (Viatris UK Healthcare Ltd) 30 patch 5 x 6 patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches (Special Order) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches (Special Order) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours transdermal patches (Ennogen Healthcare Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours transdermal patches (Ennogen Healthcare Ltd) 7 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 16 of 21 Next End

This concept is not in any reference sets

Back to Start